CHAPEL HILL, N.C.--(BUSINESS WIRE)--POZEN Inc. (NASDAQ: POZN), a pharmaceutical company focused primarily on products for the treatment of acute and chronic pain and other pain-related conditions, today announced that is has reached an agreement to amicably settle the consolidated class action lawsuit filed in the United States District Court for the Middle District of North Carolina against POZEN Inc. and Dr. John R. Plachetka, chairman, president and chief executive officer. All claims against the company and Dr. Plachetka will be dismissed in their entirety without admission of liability or wrongdoing by any party.
